2436 related articles for article (PubMed ID: 8097746)
1. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II.
Campain JA; Padmanabhan R; Hwang J; Gottesman MM; Pastan I
J Cell Physiol; 1993 May; 155(2):414-25. PubMed ID: 8097746
[TBL] [Abstract][Full Text] [Related]
2. Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II
Carvajal-Moreno J; Wang X; Hernandez VA; Mondal M; Zhao X; Yalowich JC; Elton TS
J Pharmacol Exp Ther; 2024 Apr; 389(2):186-196. PubMed ID: 38508753
[TBL] [Abstract][Full Text] [Related]
3. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U
Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087
[TBL] [Abstract][Full Text] [Related]
4. Secretion of both IL-2 and IL-4 by tumor cells results in rejection and immunity.
Strome SE; Chang AE; Shu S; Krauss JC
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):21-32. PubMed ID: 9147701
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of tumor cell adhesion and metastasis].
Saiki I
Gan To Kagaku Ryoho; 1993 Feb; 20(3):363-72. PubMed ID: 8439183
[TBL] [Abstract][Full Text] [Related]
6. Influence of an autocrine diffusible resistance factor on cell survival after exposure to therapeutic agents.
Schlehaider UK; Hill GJ; Hill HZ
Melanoma Res; 1993 Oct; 3(5):357-62. PubMed ID: 8292893
[TBL] [Abstract][Full Text] [Related]
7. Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL).
Ben-Yosef R; Braverman I; Saah D; Nagler R; Shohat S; Or R; Nagler A
Bone Marrow Transplant; 1996 Nov; 18(5):1017-9. PubMed ID: 8932860
[TBL] [Abstract][Full Text] [Related]
8. A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities.
Shitara K; Kuwana Y; Nakamura K; Tokutake Y; Ohta S; Miyaji H; Hasegawa M; Hanai N
Cancer Immunol Immunother; 1993 Jun; 36(6):373-80. PubMed ID: 8500110
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (-)-deprenyl research.
Magyar K; Szende B; Lengyel J; Tekes K
J Neural Transm Suppl; 1996; 48():29-43. PubMed ID: 8988460
[TBL] [Abstract][Full Text] [Related]
10. A case of superficial spreading melanoma in situ 2.5 mm in diameter.
Ban M; Yoneda K; Yanagihara M; Mori S; Seko T
J Dermatol; 1993 Jul; 20(7):432-5. PubMed ID: 8408926
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.
Peltenburg LT; Schrier PI
Immunogenetics; 1994; 40(1):54-61. PubMed ID: 8206526
[TBL] [Abstract][Full Text] [Related]
12. Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay.
Pötgens AJ; Lubsen NH; van Altena G; Schoenmakers JG; Ruiter DJ; de Waal RM
Thromb Haemost; 1994 Feb; 71(2):208-13. PubMed ID: 8191400
[TBL] [Abstract][Full Text] [Related]
13. A pilot experiment to compare regression of transplants of two different human tumors in athymic nude mice following single exposures to 60co radiation.
Brustad T; Rofstad EK; Davy M; Mossige J
Strahlentherapie; 1976 Nov; 152(5):477-81. PubMed ID: 996892
[TBL] [Abstract][Full Text] [Related]
14. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.
Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860
[TBL] [Abstract][Full Text] [Related]
15. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
[TBL] [Abstract][Full Text] [Related]
16. Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents.
Onishi Y; Yamaura T; Tauchi K; Sakamoto T; Tsukada K; Nunome S; Komatsu Y; Saiki I
Biol Pharm Bull; 1998 Jul; 21(7):761-5. PubMed ID: 9703264
[TBL] [Abstract][Full Text] [Related]
17. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders.
Arber DA; Tamayo R; Weiss LM
Hum Pathol; 1998 May; 29(5):498-504. PubMed ID: 9596274
[TBL] [Abstract][Full Text] [Related]
18. Prevention of peritoneal metastasis of cancer with dextran sulfate--an experimental study in mice.
Hagiwara A; Sawai K; Sakakura C; Shirasu M; Ohgaki M; Imanishi T; Yamasaki J; Togawa T; Takahashi T
Anticancer Drugs; 1997 Oct; 8(9):894-7. PubMed ID: 9402317
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
[TBL] [Abstract][Full Text] [Related]
20. The primary tumor is the primary source of metastasis in a human melanoma/SCID model. Implications for the direct autocrine and paracrine epigenetic regulation of the metastasis process.
Safarians S; Sternlicht MD; Freiman CJ; Huaman JA; Barsky SH
Int J Cancer; 1996 Apr; 66(2):151-8. PubMed ID: 8603803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
